Key result
GWAS meta-analysis identifies 130 variants with pleiotropic links across metabolic traits and inflammatory markers.
Meta-Analysis (n=85,500)
Yes
This large-scale genetic analysis identifies 25 pleiotropic gene variants linking metabolic syndrome and inflammation, providing insight into the shared genetic architecture of these cardiovascular risk factors.
Answers are grounded in this paper and cite their sources.
Pleiotropic loci link MetS traits to inflammation; leaves open causal roles pending functional validation in prospective studies.
Metabolic syndrome (MetS) has become a health and financial burden worldwide. The MetS definition captures clustering of risk factors that predict higher risk for diabetes mellitus and cardiovascular disease. Our study hypothesis is that additional to genes influencing individual MetS risk factors, genetic variants exist that influence MetS and inflammatory markers forming a predisposing MetS genetic network. To test this hypothesis a staged approach was undertaken. (a) We analyzed 17 metabolic and inflammatory traits in more than 85,500 participants from 14 large epidemiological studies within the Cross Consortia Pleiotropy Group. Individuals classified with MetS (NCEP definition), versus those without, showed on average significantly different levels for most inflammatory markers studied. (b) Paired average correlations between 8 metabolic traits and 9 inflammatory markers from the same studies as above, estimated with two methods, and factor analyses on large simulated data, helped in identifying 8 combinations of traits for follow-up in meta-analyses, out of 130,305 possible combinations between metabolic traits and inflammatory markers studied. (c) We performed correlated meta-analyses for 8 metabolic traits and 6 inflammatory markers by using existing GWAS published genetic summary results, with about 2.5 million SNPs from twelve predominantly largest GWAS consortia. These analyses yielded 130 unique SNPs/genes with pleiotropic associations (a SNP/gene associating at least one metabolic trait and one inflammatory marker). Of them twenty-five variants (seven loci newly reported) are proposed as MetS candidates. They map to genes MACF1, KIAA0754, GCKR, GRB14, COBLL1, LOC646736-IRS1, SLC39A8, NELFE, SKIV2L, STK19, TFAP2B, BAZ1B, BCL7B, TBL2, MLXIPL, LPL, TRIB1, ATXN2, HECTD4, PTPN11, ZNF664, PDXDC1, FTO, MC4R and TOMM40. Based on large data evidence, we conclude that inflammation is a feature of MetS and several gene variants show pleiotropic genetic associations across phenotypes and might explain a part of MetS correlated genetic architecture. These findings warrant further functional investigation.
No takes yet. Share an insight, caveat, or question.
Kraja et al. (2014) conducted a meta-analysis in Metabolic syndrome (n=85,500). Genetic variants was evaluated on Pleiotropic associations between metabolic traits and inflammatory markers. Meta-analyses of GWAS data identified 130 unique SNPs/genes with pleiotropic associations across metabolic traits and inflammatory markers, proposing 25 variants as metabolic syndrome candidates.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: